Cargando…

Glyoxalase 1 as a Therapeutic Target in Cancer and Cancer Stem Cells

Methylglyoxal (MG) is a dicarbonyl compound formed in cells mainly by the spontaneous degradation of the triose phosphate intermediates of glycolysis. MG is a powerful precursor of advanced glycation end products, which lead to strong dicarbonyl and oxidative stress. Although divergent functions of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji-Young, Jung, Ji-Hye, Lee, Seung-Joon, Han, Seon-Sook, Hong, Seok-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Molecular and Cellular Biology 2022
Materias:	Minireview
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794553/ https://www.ncbi.nlm.nih.gov/pubmed/36172978 http://dx.doi.org/10.14348/molcells.2022.0109

Ejemplares similares

Targeting telomerase for cancer therapeutics
por: Shay, J W, et al.
Publicado: (2008)

BC200 RNA: An Emerging Therapeutic Target and Diagnostic Marker for Human Cancer
por: Shin, Heegwon, et al.
Publicado: (2018)

Cancer heterogeneity: implications for targeted therapeutics
por: Fisher, R, et al.
Publicado: (2013)

TMPRSS4: an emerging potential therapeutic target in cancer
por: de Aberasturi, A L, et al.
Publicado: (2015)

The complexity of integrins in cancer and new scopes for therapeutic targeting
por: Hamidi, Hellyeh, et al.
Publicado: (2016)

The Role of Hippo Pathway in Cancer Stem Cell Biology
por: Park, Jae Hyung, et al.
Publicado: (2018)

Unraveling the Paradoxical Action of Androgens on Muscle Stem Cells
por: Seo, Ji-Yun, et al.
Publicado: (2019)

Topoisomerase I inhibition in colorectal cancer: biomarkers and therapeutic targets
por: Gilbert, D C, et al.
Publicado: (2012)

The therapeutic potential of targeting the EGFR family in epithelial ovarian cancer
por: Sheng, Q, et al.
Publicado: (2011)

Molecular therapeutic strategies targeting pancreatic cancer induced cachexia
por: Yakovenko, Anastasiya, et al.
Publicado: (2018)

RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets
por: Chen, Shao-Long, et al.
Publicado: (2021)

Tracing and targeting cancer stem cells: New venture for personalized molecular cancer therapy
por: Radpour, Ramin
Publicado: (2017)

Latest therapeutic target for gastric cancer: Anthrax toxin receptor 1
por: Sun, Ke-Ran, et al.
Publicado: (2021)

Stem cells, quiescence and rectal carcinoma: an unexplored relationship and potential therapeutic target
por: Buczacki, S, et al.
Publicado: (2011)

Pancreatic cancer stem cells: Perspectives on potential therapeutic approaches of pancreatic ductal adenocarcinoma
por: Di Carlo, Claudia, et al.
Publicado: (2018)

Metabolic assessment of the action of targeted cancer therapeutics using magnetic resonance spectroscopy
por: Beloueche-Babari, M, et al.
Publicado: (2010)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
por: Elaskalani, Omar, et al.
Publicado: (2017)

Therapeutic challenge for immunotherapy targeting cold colorectal cancer: A narrative review
por: Ma, Shi-Xun, et al.
Publicado: (2023)

Molecular signaling in cancer stem cells of tongue squamous cell carcinoma: Therapeutic implications and challenges
por: Joshi, Priyanka, et al.
Publicado: (2023)

Immunotherapy for pancreatic cancer
por: Yoon, Jai Hoon, et al.
Publicado: (2021)

Go-Ichi-Ni-San 2: A potential biomarker and therapeutic target in human cancers
por: Shan, Dan-Dan, et al.
Publicado: (2022)

Emerging Glycation-Based Therapeutics—Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors
por: Rabbani, Naila, et al.
Publicado: (2022)

Immunotherapy for hepatocellular carcinoma: A promising therapeutic option for advanced disease
por: Cassese, Gianluca, et al.
Publicado: (2022)

Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies
por: Jung, In-Young, et al.
Publicado: (2018)

MicroRNA Target Recognition: Insights from Transcriptome-Wide Non-Canonical Interactions
por: Seok, Heeyoung, et al.
Publicado: (2016)

Understanding the cancer stem cell
por: Bomken, S, et al.
Publicado: (2010)

Therapeutic potential of periodontal ligament stem cells
por: Queiroz, Aline, et al.
Publicado: (2021)

Emerging applications of radiomics in rectal cancer: State of the art and future perspectives
por: Hou, Min, et al.
Publicado: (2021)

Stem vs non-stem cell origin of colorectal cancer
por: Huels, D J, et al.
Publicado: (2015)

Classifying the Linkage between Adipose Tissue Inflammation and Tumor Growth through Cancer-Associated Adipocytes
por: Song, Yae Chan, et al.
Publicado: (2020)

Eph receptors as therapeutic targets in glioblastoma
por: Day, B W, et al.
Publicado: (2014)

Glyoxalase System as a Therapeutic Target against Diabetic Retinopathy
por: Aragonès, Gemma, et al.
Publicado: (2020)

Hallmarks of cancer stem cell metabolism
por: Sancho, Patricia, et al.
Publicado: (2016)

Regulators of liver cancer stem cells
por: Liu, Kai, et al.
Publicado: (2021)

Exploiting inflammation for therapeutic gain in pancreatic cancer
por: Steele, C W, et al.
Publicado: (2013)

Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets
por: Moon, Seonghyeon, et al.
Publicado: (2018)

Racial disparity in colorectal cancer: Gut microbiome and cancer stem cells
por: Goyal, Sachin, et al.
Publicado: (2016)

Apelin-APJ Signaling: a Potential Therapeutic Target for Pulmonary Arterial Hypertension
por: Kim, Jongmin
Publicado: (2014)

Emerging Role of NRF2 Signaling in Cancer Stem Cell Phenotype
por: Hallis, Steffanus P., et al.
Publicado: (2023)

Golgi Stress Response: New Insights into the Pathogenesis and Therapeutic Targets of Human Diseases
por: Kim, Won Kyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jhhq2hnre2sq1mfbrjnigju4tl